Abstract
The need to reduce analysis time when controlling impurities in medicinal products remains an urgent challenge. The aim of the study was to use the example of ciprofloxacin in order to select chromatographic conditions that will significantly accelerate and simplify determination of impurities in medicinal products. Methods: the study was performed using the Chromolith ® Performance RP-18e 100×4.6 mm and Acquity UPLC BEH C18 1.7 μ m, 100×2.1 mm columns and the Agilent 1290 Infinity chromatography system with a diode array detector. Results: the authors of the study worked out gradient elution modes for determination of ciprofloxacin impurities that involved 15 min run time for fast high-performance liquid chromatography and 12 min run time for ultra-performance liquid chromatography. The identification of impurities was performed based on relative retention times of impurity peaks and their comparison with the reference standard chromatogram. Conclusions: the study demonstrated the possibility of replacing the thin-layer chromatography method used for determination of fluoroquinolonic acid (ciprofloxacin impurity A) with high-performance liquid chromatography. The proposed test conditions allow for identification of ciprofloxacin impurities specified in well-established pharmacopoeias and manufacturers’ product specification files. The obtained data may be used for further development of rapid methods of ciprofloxacin impurities determination in medicinal products.
Highlights
Необходимость сокращения времени анализа при мониторинге содержания примесей в лекарственных средствах является актуальной проблемой
The aim of the study was to use the example of ciprofloxacin in order to select chromatographic conditions that will significantly accelerate and simplify determination of impurities in medicinal products
Results: the authors of the study worked out gradient elution modes for determination of ciprofloxacin impurities that involved 15 min run time for fast high-performance liquid chromatography and 12 min run time for ultra-performance liquid chromatography
Summary
Необходимость сокращения времени анализа при мониторинге содержания примесей в лекарственных средствах является актуальной проблемой. Цель работы: выбор условий хроматографирования, позволяющих значительно ускорить и упростить определение примесей в лекарственных средствах на примере анализа ципрофлоксацина. На основе полученных данных возможна дальнейшая разработка экспрессных методик определения примесей ципрофлоксацина в лекарственных средствах. Conclusions: the study demonstrated the possibility of replacing the thin-layer chromatography method used for determination of fluoroquinolonic acid (ciprofloxacin impurity A) with high-performance liquid chromatography. Improvement of Tests for the Control of Impurities in Antimicrobial Medicinal Products by Chromatographic Methods: Ciprofloxacin Case Study. Мониторинг содержания органических примесей в лекарственных средствах является необходимым как на этапе производства, так и при оценке качества готового продукта. Препараты ципрофлоксацина широко используются в клинической практике и представлены на фармацевтическом рынке Российской Федерации в различных лекарственных формах (твердые лекарственные формы для приема внутрь, глазные капли, растворы для инфузий)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have